08/19/2008- Dear Dr. Gott: I took Zelnorm over a year ago, until my doctor said the Food and Drug Administration had taken it off the market and it was no longer available. More ::

08/05/2008- If you suffer from allergy symptoms, you could be at risk for developing irritable bowel syndrome. Researchers at Rush University Medical Center in Chicago recently noted that individuals with hay fever are more than twice as likely to have irritable bowel syndrome (IBS) than those who are unaffected by seasonal allergies. More ::

04/05/2008-Having restricted its use last year, Novartis has now served notice that it intends to take its irritable bowel syndrome off the US market completely. The Swiss drugs giant has notified the US Food and Drug Administration that it will no longer provide Zelnorm (tegaserod maleate) as part of a restricted programme agreed with the agency in July last year. That agreement saw Novartis provide the drug to treat IBS with constipation and chronic idiopathic constipation in women younger than 55 who meet certain conditions. More ::

10/14/2007 - Recently, there has been a product called Zelnorm, which was used to treat Irritable Bowel Syndrome and constipation. However, Zelnorm has been withdrawn from the market in the U.S. because there seemed to be an increase in life-threatening heart disease and strokes in people taking the drug. More ::

09/30/2007 - The removal of Zelnorm from pharmacy shelves in March was terrifying for Lisa Wollack and others with gastroparesis, a condition in which food and water just sit and sit in the stomach. More ::

09/24/2007 - Coming up with drugs that belong on the radar - and prescription pads - of primary-care doctors is "a challenge that biotech is treading carefully on," as Peter Hecht, CEO of Microbia Inc., told BioWorld Financial Watch last week, but Hecht's firm made a major footfall into the zone with its potential $330 million deal with Forest Laboratories Inc. More ::

09/12/2007 - Swiss drugmaker Novartis is ready to increase cash returns to shareholders, its chairman and chief executive said on Wednesday. More ::

03/31/2007 - A widely prescribed drug for severe constipation is being taken off the market after it was linked to a higher risk of heart attacks and strokes, federal regulators said. More ::

03/30/2007 - The Food and Drug Administration (FDA) has requested that Novartis Pharmaceuticals Corporation of East Hanover, New Jersey, voluntarily discontinue marketing of Zelnorm (tegaserod) based on the recently identified finding of an increased risk of serious cardiovascular adverse events (heart problems) associated with use of the drug. Novartis has agreed to voluntarily suspend marketing of the drug in the United States. More ::

03/30/2007 - Swiss pharmaceutical maker Novartis AG will stop selling a drug to relieve constipation after it was linked to a higher chance of heart attack, stroke and worsening heart chest pain that can become a heart attack, federal health officials said Friday. More ::

If you or a loved one have experienced Zelnorm side effects such as severe chest pain, heart attack, or stroke you may be entitled to compensation. Contact the Zelnorm attorneys of Ennis & Ennis today for a free confidential case evaluation. Our on staff nurse and attorneys are standing by to answer any questions you may have regarding Zelnorm side effects, a possible Zelnorm class action lawsuit, or any other type of Zelnorm litigation.